Aura Announces Q3 2025 and 9M 2025 Financial and Operational Results

Aura Announces Q3 2025 and 9M 2025 Financial and Operational Results GlobeNewswire November 04, 2025 ROAD TOWN, British Virgin Islands, Nov. 04, 2025 (GLOBE NEWSWIRE) — Aura Minerals Inc. (NASDAQ: AUGO) (B3: AURA33) (“Aura” or the “Company”) announces that it has filed its audited consolidated financial statements and earnings release (together, “Financial and Operational Results”) […]

Heartland Forward and The Rockefeller Foundation Host “Big Bets for America” to Elevate Solutions Powering the Future

Convening in Oklahoma City brought together more than 200 stakeholders, spanning leading businesses, organizations, governments and philanthropies, focused on helping communities flourish across the heartland and beyond. Heartland Forward and The Rockefeller Foundation co-hosted Big Bets for America: Oklahoma City, a one-day gathering of policymakers, philanthropists, investors, entrepreneurs and industry leaders.More than 200 leaders engaged

Class Action Lawsuit Filed: Fluor Corporation (FLR) – Join by November 14, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 4, 2025 / If you suffered a loss on your Fluor Corporation (NYSE:FLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluor-corporation-lawsuit-submission-form?prid=175543&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

AVTR LAWSUIT ALERT: Levi & Korsinsky Notifies Avantor, Inc. Investors – Lead Plaintiff Deadline December 29, 2025

NEW YORK, NY / ACCESS Newswire / November 4, 2025 / If you suffered a loss on your Avantor, Inc. (NYSE:AVTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avantor-inc-lawsuit-submission-form?prid=175544&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Levi & Korsinsky Investigating Whether Stride, Inc. (LRN) Misled Investors – Securities Law Violations Possible

NEW YORK, NY / ACCESS Newswire / November 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stride, Inc. ("Stride, Inc.") (NYSE:LRN) concerning possible violations of federal securities laws. On October 28, 2025, Stride reported its first quarter fiscal 2026 earnings after market. While earnings beat expectations, enrollment numbers

Nabors Comments on Upgrades to Credit Ratings

Nabors Industries Ltd.(“Nabors” or the “Company”) (NYSE: NBR) today commented on the recent credit ratings actions taken by all three of the major credit rating agencies. Coincident with Nabors recent offering of Senior Preferred Guaranteed Notes due in 2032 (“SPGN”), each of the agencies has issued certain credit ratings. Two of the agencies upgraded their

Mesoblast to Meet With FDA Next Month to Discuss Rexlemestrocel-L and Opioid Cessation

(AUST:MSB.AX),(NASDAQ:MESO), NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the U.S. Food & Drug Administration (FDA) has scheduled a meeting in early December to discuss Mesoblast's data on opioid reduction and cessation from its first Phase 3 study (MSB-DR003)

Mesoblast to Meet With FDA Next Month to Discuss Rexlemestrocel-L and Opioid Cessation

Mesoblast to Meet With FDA Next Month to Discuss Rexlemestrocel-L and Opioid Cessation GlobeNewswire November 04, 2025 NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the U.S. Food & Drug Administration (FDA) has scheduled a meeting in early December

WAL Investor News: If You Have Suffered Losses in Western Alliance Bancorporation (NYSE: WAL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

(NYSE:WAL), NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western Alliance Bancorporation (NYSE: WAL) resulting from allegations that Western Alliance Bancorporation may have issued materially misleading business information to the investing public. SO WHAT:

WAL Investor News: If You Have Suffered Losses in Western Alliance Bancorporation (NYSE: WAL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

WAL Investor News: If You Have Suffered Losses in Western Alliance Bancorporation (NYSE: WAL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire November 04, 2025 NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on

Scroll to Top